RNS Number : 7052Z Renalytix AI PLC 25 May 2021 Renalytix AI plc ("Renalytix" or the "Company") Director/PDMR Dealing New York , 25 May 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by James McCullough , the Company's Chief Executive Officer, of 10,462
RNS Number : 4140Z Renalytix AI PLC 21 May 2021 Renalytix AI plc ("Renalytix" or the "Company") Director/PDMR Dealing New York , 21 May 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by James McCullough , the Company's Chief Executive Officer, of 54,538
RNS Number : 1113Z Renalytix AI PLC 19 May 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") ATRIUM HEALTH, WAKE FOREST BAPTIST HEALTH, WAKE FOREST SCHOOL OF MEDICINE AND RENALYTIX PARTNER TO ADVANCE KIDNEY HEALTH Partnership marks a long-term commitment to reducing impact of
RNS Number : 3487W Renalytix AI PLC 22 April 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 3466W Renalytix AI PLC 22 April 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 3204W Renalytix AI PLC 22 April 2021 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 3183W Renalytix AI PLC 22 April 2021 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 2366W Renalytix AI PLC 22 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing KidneyIntelX Testing Services Available to 140 U.S.
RNS Number : 9600V Renalytix AI PLC 20 April 2021 Renalytix AI plc (" RenalytixAI " or the " Company ") KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS) Data from 1,325 CANVAS Participants with
RNS Number : 8100V Renalytix AI PLC 19 April 2021 Renalytix AI plc Director/PDMR Shareholding New York , 19 April 2021 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence -enabled in vitro diagnostics company, focused on optimizing